10/16/2025
3:41 PM | Bicara Therapeutics (Issuer)
Cohlhepp Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2025
3:13 PM | Bicara Therapeutics (Subject)
Mazumdar Claire (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/15/2025
5:00 PM | Bicara Therapeutics (Issuer)
Mazumdar Claire (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2025
3:18 PM | Bicara Therapeutics (Subject)
Mazumdar Claire (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/15/2025
3:20 PM | Bicara Therapeutics (Subject)
Cohlhepp Ryan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/14/2025
8:05 AM | Bicara Therapeutics (Subject)
Mazumdar Claire (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/10/2025
4:22 PM | Bicara Therapeutics (Issuer)
Hyep Ivan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2025
4:23 PM | Bicara Therapeutics (Issuer)
Raben David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/09/2025
3:31 PM | Bicara Therapeutics (Subject)
Hyep Ivan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/08/2025
4:33 PM | Bicara Therapeutics (Issuer)
Cohlhepp Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2025
4:33 PM | Bicara Therapeutics (Issuer)
Hyep Ivan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
10/08/2025
3:04 PM | Bicara Therapeutics (Subject)
Hyep Ivan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/07/2025
3:20 PM | Bicara Therapeutics (Subject)
Hyep Ivan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/07/2025
3:07 PM | Bicara Therapeutics (Subject)
Cohlhepp Ryan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/06/2025
3:36 PM | Bicara Therapeutics (Subject)
Cohlhepp Ryan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/06/2025
3:07 PM | Bicara Therapeutics (Subject)
Hyep Ivan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/29/2025
3:38 PM | Bicara Therapeutics (Subject)
Meisner Lara (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/17/2025
4:01 PM | Bicara Therapeutics (Issuer)
Meisner Lara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2025
6:41 AM | Bicara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2025
1:56 PM | Bicara Therapeutics (Subject)
Invus Global Management, LLC (Filed by)
| Form SCHEDULE 13G/A | |
07/17/2025
10:08 AM | Bicara Therapeutics (Subject)
FMR LLC (Filed by)
| Form SCHEDULE 13G/A | |
07/17/2025
10:11 AM | Bicara Therapeutics (Subject)
FMR LLC (Filed by)
| Form SCHEDULE 13G | |
06/18/2025
4:12 PM | Bicara Therapeutics (Issuer)
Meisner Lara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
3:33 PM | Bicara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2025
3:34 PM | Bicara Therapeutics (Issuer)
RA Capital Nexus Fund III, L.P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2025
3:37 PM | Bicara Therapeutics (Issuer)
Haviland Kate (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2025
3:26 PM | Bicara Therapeutics (Issuer)
Bowden Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2025
3:27 PM | Bicara Therapeutics (Issuer)
Simson Jake (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2025
3:28 PM | Bicara Therapeutics (Issuer)
Robertson Scott M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
6:43 AM | Bicara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2025
8:12 AM | Bicara Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/27/2025
6:45 AM | Bicara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2025
5:35 PM | Bicara Therapeutics (Issuer)
Meisner Lara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2025
3:21 PM | Bicara Therapeutics (Subject)
Meisner Lara (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
8:14 AM | Bicara Therapeutics (Subject)
FMR LLC (Filed by)
| Form SCHEDULE 13G | |
01/13/2025
7:02 AM | Bicara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
